agutab 500 tablet upto 20% off seamco roha

agutab 500 tablet upto 20% off seamco roha

Agutab 500 Tablet: An Anti-Malarial Medication

Agutab 60 Tablet manufactured by Seamco, Roha is primarily used for the prevention and treatment of malaria. It contains the active ingredient Artemether, which is an antimalarial drug.

Key Points about Agutab 60 Tablet

• Active Ingredient: Artemether
• Manufacturer: Seamco, Roha
• Dosage: 60mg
• Primary Use: Prevention and treatment of malaria
• Importance: Malaria is a serious mosquito-borne disease, and timely medication is crucial for prevention and treatment.

Important Considerations

• Malaria Prevention: Agutab 60 can be used as a preventive measure for individuals traveling to malaria-prone regions.
• Treatment: It’s also effective in treating acute uncomplicated malaria.
• Medical Supervision: Always consult a healthcare professional before using Agutab 60.
• Complete the Course: It’s essential to complete the full course of medication as prescribed by the doctor, even if symptoms improve.
• Side Effects: Like any medication, Agutab 60 can have side effects. Consult the product information leaflet or your doctor for details.

Note: While Agutab 60 is an effective antimalarial drug, prevention remains the best strategy. Using mosquito repellents, wearing protective clothing, and staying in screened accommodations can significantly reduce the risk of malaria.

Malaria is a mosquito-borne infectious disease that affects vertebrates.[6][7][3] Human malaria causes symptoms that typically include fever, fatigue, vomiting, and headaches.[1][8] In severe cases, it can cause jaundice, seizures, coma, or death.[1][9] Symptoms usually begin 10 to 15 days after being bitten by an infected Anopheles mosquito.[10][4] If not properly treated, people may have recurrences of the disease months later.[3] In those who have recently survived an infection, reinfection usually causes milder symptoms.[1] This partial resistance disappears over months to years if the person has no continuing exposure to malaria.[1]

Human malaria is caused by single-celled microorganisms of the Plasmodium group.[10] It is spread exclusively through bites of infected female Anopheles mosquitoes.[10][11] The mosquito bite introduces the parasites from the mosquito’s saliva into a person’s blood.[3] The parasites travel to the liver, where they mature and reproduce.[1] Five species of Plasmodium commonly infect humans.[10] The three species associated with more severe cases are P. falciparum (which is responsible for the vast majority of malaria deaths), P. vivax, and P. knowlesi (a simian malaria that spills over into thousands of people a year).[12][13] P. ovale and P. malariae generally cause a milder form of malaria.[1][10] Malaria is typically diagnosed by the microscopic examination of blood using blood films, or with antigen-based rapid diagnostic tests.[1] Methods that use the polymerase chain reaction to detect the parasite’s DNA have been developed, but they are not widely used in areas where malaria is common, due to their cost and complexity.[14]

The risk of disease can be reduced by preventing mosquito bites through the use of mosquito nets and insect repellents or with mosquito-control measures such as spraying insecticides and draining standing water.[1] Several medications are available to prevent malaria for travellers in areas where the disease is common.[3] Occasional doses of the combination medication sulfadoxine/pyrimethamine are recommended in infants and after the first trimester of pregnancy in areas with high rates of malaria.[3] As of 2023, two malaria vaccines have been endorsed by the World Health Organization.[15] The recommended treatment for malaria is a combination of antimalarial medications that includes artemisinin.[16][17][1][3] The second medication may be either mefloquine, lumefantrine, or sulfadoxine/pyrimethamine.[18] Quinine, along with doxycycline, may be used if artemisinin is not available.[18] In areas where the disease is common, malaria should be confirmed if possible before treatment is started due to concerns of increasing drug resistance.[3] Resistance among the parasites has developed to several antimalarial medications; for example, chloroquine-resistant P. falciparum has spread to most malarial areas, and resistance to artemisinin has become a problem in some parts of Southeast Asia.[3]

agutab 500 tablet agutab 500 tablet agutab 500 tablet agutab 500 tablet agutab 500 tablet